WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
China's new factory data evidence of good momentum in its economy: FM spokespersonFriendship Blossoms on the Belt and Road3 killed in military helicopter crash in Cuba7.3 magnitude quake strikes TaiwanMexican embassy staff leave Ecuador after break in diplomatic tiesProfile: President of Suriname Chandrikapersad SantokhiXi Meets Antigua and Barbuda's Prime MinisterSevere convection causes 4 deaths, more than 10 injuries in E ChinaGreek port project helps boost career prospectsChile to recall ambassador from Venezuela for consultations